Trials / Unknown
UnknownNCT03581656
ChordArt System for Mitral Regurgitation
ChordArt System Study for the Treatment of Mitral Regurgitation Due to Leaflet Prolapse or Flail
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- CoreMedic GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The ChordArt System is a novel catheter based technology for mitral chordal replacement that enables controlled implantation of artificial mitral chords to treat mitral regurgitation with a minimally invasive approach. The implant is designed to allow transfemoral antegrade implantation.
Detailed description
ChordArt utilizes a minimally invasive catheter based approach by which multiple artificial chordae are precisely positioned into the papillary muscle and then secured to the pathological leaflet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ChordArt System | The ChordArt System is intended for chordal replacement in mitral valve insufficiency due to leaflet prolapse or flail. One or more ChordArt System may be utilized within the same intervention for optimal mitral valve treatment. |
Timeline
- Start date
- 2018-03-21
- Primary completion
- 2023-09-10
- Completion
- 2023-12-01
- First posted
- 2018-07-10
- Last updated
- 2022-07-12
Locations
1 site across 1 country: Lithuania
Source: ClinicalTrials.gov record NCT03581656. Inclusion in this directory is not an endorsement.